loading
Xtant Medical Holdings Inc stock is traded at $0.4399, with a volume of 19,378. It is up +2.61% in the last 24 hours and up +4.12% over the past month. Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers various products to treat a range of spinal and sacroiliac conditions, including trauma, degeneration, deformity, and tumor. Xtant Medical Holdings, Inc. markets its products through direct sales, consignment agents, reseller distributors, private label distributors, and technology licensees. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
See More
Previous Close:
$0.4287
Open:
$0.4422
24h Volume:
19,378
Relative Volume:
0.17
Market Cap:
$61.70M
Revenue:
$121.91M
Net Income/Loss:
$1.83M
P/E Ratio:
40.36
EPS:
0.0109
Net Cash Flow:
$7.75M
1W Performance:
-2.22%
1M Performance:
+4.12%
6M Performance:
-28.33%
1Y Performance:
-29.05%
1-Day Range:
Value
$0.41
$0.4489
1-Week Range:
Value
$0.4099
$0.4489
52-Week Range:
Value
$0.3887
$0.95

Xtant Medical Holdings Inc Stock (XTNT) Company Profile

Name
Name
Xtant Medical Holdings Inc
Name
Phone
406-388-0480
Name
Address
664 Cruiser Lane, Belgrade, MT
Name
Employee
174
Name
Twitter
@xtantmedical
Name
Next Earnings Date
2026-08-11
Name
Latest SEC Filings
Name
XTNT's Discussions on Twitter

Compare XTNT vs ABT, SYK, MDT, BSX, EW

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
XTNT icon
XTNT
Xtant Medical Holdings Inc
0.4399 61.70M 121.91M 1.83M 7.75M 0.0109
ABT icon
ABT
Abbott Laboratories
104.49 182.00B 46.59B 5.41B 7.38B 3.0938
SYK icon
SYK
Stryker Corp
336.74 129.09B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
84.22 107.81B 36.36B 4.84B 5.43B 3.7261
BSX icon
BSX
Boston Scientific Corp
45.51 67.64B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
83.04 47.81B 6.30B 1.07B 1.09B 1.8406

Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-05-23 Initiated BTIG Research Buy
Nov-15-18 Reiterated Maxim Group Buy
Feb-14-18 Reiterated Maxim Group Buy

Xtant Medical Holdings Inc Stock (XTNT) Latest News

pulisher
12:52 PM

Xtant Medical Holdings Inc (XTNT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

12:52 PM
pulisher
Jul 26, 2026

XTNT|Xtant Medical Holdings Inc|Price:0.429|Chg%:-0.003 - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

Xtant Medical Holdings Inc (XTNT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 25, 2026
pulisher
Jul 24, 2026

XTNT|Xtant Medical Holdings Inc|Price:0.429|Chg%:-0.001 - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Xtant Medical Holdings Inc (XTNT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026
pulisher
Jul 17, 2026

XTNT Q1 2026 Earnings: EPS Misses Estimates Despite Modest Stock GainCore Business Growth - dars.gov.et

Jul 17, 2026
pulisher
Jul 16, 2026

XTNT stock trades around recent lows as Xtant Medical revenue climbs and losses narrow - Ad-hoc-news.de

Jul 16, 2026
pulisher
Jul 15, 2026

SemiLEDs And 2 Other Promising Penny Stocks To Watch - simplywall.st

Jul 15, 2026
pulisher
Jul 12, 2026

Xtant Medical Holdings (XTNT) Holds Steady at $0.42 as Traders Eye Key LevelsPut Wall - dars.gov.et

Jul 12, 2026
pulisher
Jul 10, 2026

XTNT Q1 2026 Earnings: EPS Misses Estimates as Revenue Remains Unreported Amid Stock DeclineEarnings Season Outlook - dars.gov.et

Jul 10, 2026
pulisher
Jul 09, 2026

XTNT stock reflects niche spine focus as regenerative implants underpin the business - Ad-hoc-news.de

Jul 09, 2026
pulisher
Jul 09, 2026

Xtant Medical Q1 2026 Earnings: EPS Misses Estimates Despite Positive Market ReactionNew Analyst Coverage - dars.gov.et

Jul 09, 2026
pulisher
Jul 07, 2026

Xtant Medical Holdings outlines spine surgery focus as investors watch growth path - Ad Hoc News

Jul 07, 2026
pulisher
Jul 03, 2026

XTNT Q1 2026 Earnings: EPS Misses Estimates as Loss WidensEarnings Volatility Report - dars.gov.et

Jul 03, 2026
pulisher
Jul 03, 2026

Xtant Medical Holdings (XTNT) Pressures Support at $0.39 After 1.67% DeclineTrend Continuation Trade - dars.gov.et

Jul 03, 2026
pulisher
Jun 26, 2026

Xtant Medical Holdings Inc (XTNT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 26, 2026
pulisher
Jun 26, 2026

XTNT, Friday review points to sector peers and shares - AD HOC NEWS

Jun 26, 2026
pulisher
Jun 26, 2026

Enterprise value to EBITDA forward of Xtant Medical Holdings, Inc. – AMEX:XTNT - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Enterprise value to EBIT forward of Xtant Medical Holdings, Inc. – AMEX:XTNT - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

XTNT Q1 2026 Earnings: EPS Misses Estimates, Revenue Not DisclosedLow Estimate Range - DonanımHaber

Jun 26, 2026
pulisher
Jun 25, 2026

XTNT Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Xtant Medical Holdings, Inc. Actuals & Estimates (AMEX:XTNT) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Price to sales forward of Xtant Medical Holdings, Inc. – AMEX:XTNT - TradingView

Jun 25, 2026
pulisher
Jun 23, 2026

Xtant Medical (NASDAQ: XTNT) details 2026 annual meeting, director slate and pay - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

[ARS] Xtant Medical Holdings, Inc. SEC Filing - Stock Titan

Jun 23, 2026
pulisher
Jun 21, 2026

Xtant Medical Holdings StockBackground and strategy snapshot - AD HOC NEWS

Jun 21, 2026
pulisher
Jun 19, 2026

Xtant Medical Holdings Inc (XTNT) Institutional Confidence - TradingKey

Jun 19, 2026
pulisher
Jun 18, 2026

Xtant Medical Holdings Inc (XTNT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Xtant Medical Holdings Inc (XTNT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

Xtant Medical Holdings Inc (XTNT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 15, 2026

Xtant Medical Holdings (XTNT) Holds at $0.45 as Micro-Cap Medical Stock Tests Key ResistanceDealer Delta - newsline.com

Jun 15, 2026
pulisher
Jun 08, 2026

XTNT Technical Analysis | Trend, Signals & Chart Patterns - ChartMill

Jun 08, 2026
pulisher
Jun 06, 2026

XTNT Hovers Near Support Amid Consolidation in Small-Cap MedTechPercent Above MA - newsline.com

Jun 06, 2026
pulisher
Jun 05, 2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped - Morningstar

Jun 05, 2026
pulisher
May 31, 2026

XTNT Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesEarnings Sentiment Score - DonanımHaber

May 31, 2026
pulisher
May 29, 2026

XTNT Q1 2026 Earnings: EPS Misses Estimates as Company Reports Wider-than-Expected Loss; Stock Rises 2.17%Mid-Term Outlook - dars.gov.et

May 29, 2026
pulisher
May 27, 2026

Xtant Medical Holdings (XTNT) Inches Higher as Stock Consolidates Near Key SupportBPI Bull Correction - The Legal Advocate

May 27, 2026
pulisher
May 26, 2026

Xtant Medical Holdings (XTNT) Tests Key Support Level After Recent DeclineCall Flow Alert - Město Břeclav

May 26, 2026
pulisher
May 25, 2026

Xtant outlines $95M-$99M 2026 revenue outlook as Companion Spine divestiture and Q-code license revenue roll off - MSN

May 25, 2026
pulisher
May 24, 2026

XTNT Q1 2026 Earnings: EPS Misses Estimates Despite Stock GainCommunity Hot Stocks - Newser

May 24, 2026
pulisher
May 24, 2026

QTEX Stock Price and Chart — NASDAQ:QTEX - TradingView

May 24, 2026
pulisher
May 23, 2026

Xtant Medical Holdings Inc. (XTNT) Q1 2026 Earnings: EPS Misses Estimates Amidst Narrow LossSenior Analyst Forecasts - Newser

May 23, 2026
pulisher
May 22, 2026

Xtant Medical Holdings (XTNT) Edges Higher: Testing Key Resistance at $0.50Shared Buy Zones - Newser

May 22, 2026
pulisher
May 22, 2026

Xtant Medical Holdings Holds Near Key Resistance Level After Modest GainCommunity Chart Signals - Newser

May 22, 2026
pulisher
May 22, 2026

Xtant Medical Holdings (XTNT) Gains 2.08% as Stock Approaches Key Resistance at $0.50Profitability Factor - Newser

May 22, 2026
pulisher
May 20, 2026

Xtant Medical Balances New Growth Bets With Near-Term Pain - TipRanks

May 20, 2026
pulisher
May 19, 2026

Xtant Medical launches pre-shaped bone graft product line By Investing.com - Investing.com Nigeria

May 19, 2026
pulisher
May 18, 2026

XTNT SEC FilingsXtant Medical 10-K, 10-Q, 8-K Forms - Stock Titan

May 18, 2026
pulisher
May 16, 2026

Xtant Medical raises FY 2026 revenue guidance to $101M-$105M as it adds HEMOBLAST distribution rights - MSN

May 16, 2026
pulisher
May 15, 2026

Xtant Medical Q1 Earnings Call Highlights - Yahoo Finance

May 15, 2026

Xtant Medical Holdings Inc Stock (XTNT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
ZBH ZBH
$92.07
price up icon 0.79%
STE STE
$218.40
price up icon 2.02%
PHG PHG
$25.02
price down icon 4.39%
$61.12
price up icon 0.89%
$73.37
price up icon 2.56%
EW EW
$83.04
price up icon 0.50%
Cap:     |  Volume (24h):